We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16.5B
AUM Growth
+$861M
Cap. Flow
+$217M
Cap. Flow %
1.32%
Top 10 Hldgs %
30.08%
Holding
735
New
44
Increased
335
Reduced
212
Closed
49

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$60.1M
2
QCOM icon
Qualcomm
QCOM
+$53.4M
3
NU icon
Nu Holdings
NU
+$48.5M
4
AMZN icon
Amazon
AMZN
+$46.5M
5
BMA icon
Banco Macro
BMA
+$43.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.8M
2
ADBE icon
Adobe
ADBE
+$36.1M
3
VIPS icon
Vipshop
VIPS
+$33.1M
4
SBUX icon
Starbucks
SBUX
+$31.4M
5
LOW icon
Lowe's Companies
LOW
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Healthcare 27.47%
3 Financials 9.69%
4 Consumer Discretionary 7.72%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KSPI icon
276
Kaspi.kz JSC
KSPI
$16.4B
$8.41M 0.05%
+65,200
New +$7.99M
BBY icon
277
Best Buy
BBY
$18.6B
$8.31M 0.05%
98,561
+5,056
+5% +$401K
DELL icon
278
Dell
DELL
$276B
$8.3M 0.05%
60,179
-167,399
-74% -$22.4M
MAC icon
279
Macerich
MAC
$7.41B
$8.16M 0.05%
528,252
+306,509
+138% +$4.69M
VIPS icon
280
Vipshop
VIPS
$7.08B
$8.05M 0.05%
28,000
-2,081,751
-99% -$33.1M
RL icon
281
Ralph Lauren
RL
$22.6B
$7.92M 0.05%
+45,262
New +$7.82M
SLG icon
282
SL Green Realty
SLG
$3.83B
$7.79M 0.05%
137,533
-20,328
-13% -$1.07M
MNSO icon
283
MINISO
MNSO
$3.72B
$7.67M 0.05%
30,500
-80,000
-72% -$1.76M
BMI icon
284
Badger Meter
BMI
$3.71B
$7.62M 0.05%
40,898
-14,449
-26% -$2.64M
ITOS
285
DELISTED
iTeos Therapeutics
ITOS
$7.56M 0.05%
+509,303
New +$7.3M
DE icon
286
Deere & Co
DE
$169B
$7.35M 0.04%
19,660
+1,453
+8% +$567K
MORF
287
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$7.3M 0.04%
214,154
-35,779
-14% -$1.06M
SCHW
288
Charles Schwab
SCHW
$181B
$7.24M 0.04%
98,226
+8,118
+9% +$600K
ONT
289
Onterris Inc
ONT
$718M
$7.21M 0.04%
161,885
+8,786
+6% +$395K
JBL icon
290
Jabil
JBL
$32.6B
$7.15M 0.04%
65,684
-37,628
-36% -$4.56M
KYMR icon
291
Kymera Therapeutics
KYMR
$9.05B
$7.11M 0.04%
238,165
-90,137
-27% -$3.12M
SNOW icon
292
Snowflake
SNOW
$94.6B
$7.06M 0.04%
52,289
+14,970
+40% +$2.21M
ETNB
293
DELISTED
89bio
ETNB
$6.79M 0.04%
848,079
+538,079
+174% +$4.8M
NEO icon
294
NeoGenomics
NEO
$1.71B
$6.75M 0.04%
487,026
+112,009
+30% +$1.59M
OMC icon
295
Omnicom Group
OMC
$23.5B
$6.75M 0.04%
75,218
+17,287
+30% +$1.61M
TSCO icon
296
Tractor Supply
TSCO
$16.7B
$6.71M 0.04%
124,180
-25,310
-17% -$1.36M
SRE icon
297
Sempra
SRE
$59.7B
$6.7M 0.04%
88,150
+2,987
+4% +$221K
WCC
298
WESCO International
WCC
$16.5B
$6.62M 0.04%
+41,762
New +$7.11M
OPCH icon
299
Option Care Health
OPCH
$3.42B
$6.58M 0.04%
237,555
+9,471
+4% +$282K
CHD icon
300
Church & Dwight Co
CHD
$23.4B
$6.45M 0.04%
62,247
+2,812
+5% +$297K

Similar funds

Candriam SCA's Q2 2024 Portfolio in Review

As of Q2 2024, Candriam SCA held 735 positions worth $16.5B, up 5.5% from $15.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q2 2024 filing shows 44 new, 335 increased, 212 reduced and 49 closed positions. Its largest new stake was Banco Macro: 754,200 shares worth $43.2M. The largest sale was Apple, an estimated $40.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2024 buy was Banco Macro: 754,200 shares worth $43.2M.
  • Candriam SCA added most to Eli Lilly in Q2 2024, an estimated $60.1M increase.
  • Candriam SCA's biggest Q2 2024 reduction was Apple, cutting an estimated $40.8M.
  • Candriam SCA fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $16.5M.
  • Candriam SCA's ten largest holdings make up 30% of its $16.5B portfolio in Q2 2024.
  • Candriam SCA opened 44 new positions and closed 49 in Q2 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $16.5B.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.